Company Filing History:
Years Active: 2013
Title: Juergen Braunger: Innovator in Anti-Proliferative Compounds
Introduction
Juergen Braunger is a notable inventor based in Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that exhibit anti-proliferative and apoptosis-inducing activities. His work is essential in the ongoing fight against various diseases, including cancer.
Latest Patents
Juergen Braunger holds a patent titled "Indolopyridines As Eg5 Kinesin Modulators." This patent describes compounds of a specific formula, where R1, R2, R3, R4, R5, and R6 have defined meanings as indicated in the description. These compounds are recognized for their effectiveness in promoting anti-proliferative and apoptosis-inducing activities.
Career Highlights
Juergen Braunger is currently employed at 4SC AG, a company dedicated to the development of innovative therapies for cancer and autoimmune diseases. His role at the company allows him to apply his expertise in medicinal chemistry to create impactful solutions in healthcare.
Collaborations
Throughout his career, Juergen has collaborated with notable colleagues, including Matthias Vennemann and Thomas Baer. These collaborations have contributed to the advancement of research and development in their respective fields.
Conclusion
Juergen Braunger is a distinguished inventor whose work in anti-proliferative compounds is paving the way for new therapeutic options. His contributions to medicinal chemistry are invaluable, and his ongoing research continues to inspire advancements in healthcare.